Macrogenics Inc (NASDAQ: MGNX): The Best-Of-Breed For Investing?
Bellevue Asset Management AG recently announced the acquisition of new stake in Macrogenics Inc (NASDAQ:MGNX). The institutional investor has increased its shareholding in the Healthcare company by 1.29% to 9.93 million shares with purchase of 0.13 million shares. This fresh investment now brings its stake to 16.01% valued currently at $81.52 million. In addition, T. […]
